Back

RxCe.com LLC

  • Anticonvulsants
  • Bipolar Disorder
  • Lamotrigine
  • Sleep Deprivation

Managing Bipolar Disorder in Childbearing Women

Bipolar disorder is a common and serious psychiatric condition with disabling consequences. Women have the highest risk of being diagnosed with bipolar or having a recurring episode during pregnancy or within one year of giving birth. Sleep deprivation in postpartum women can lead to worsening of the patient’s bipolar disorder. In pregnant and postpartum women who are diagnosed with bipolar disorder, lithium is considered the gold standard for the treatment of bipolar disorder. Lithium can be an effective treatment for controlling symptoms. However, fluctuations in serum lithium levels can lead to subtherapeutic levels during the first and second trimesters and supratherapeutic or even toxic levels in the third trimester and postpartum period. In addition, lithium use during pregnancy carries risks. The American College of Obstetricians and Gynecologists issued new guidelines for lithium use during pregnancy and postpartum to address these risks. In cases where lithium is not preferred, other medications may be appropriate. For example, lamotrigine, an anticonvulsant, is widely considered non-teratogenic and is often used as a safe alternative to lithium in pregnancy.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 3 creditsAAPA Category 1 Credit™Up to 3 creditsAMA PRA Category 1 Credit™Up to 3 creditsPharmacyUp to 3 credits

MOC types

ABIM — Medical KnowledgeUp to 3 pointsABIM — Practice AssessmentUp to 3 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

$8.99

Standard

Listed by the provider · rxce.com

  • Enduring / On-demand
  • Credit · Up to 3 credits
  • MOC · Up to 3 points
  • $8.99
  • Released
    May 1, 2026
  • Last day to claim credit
    May 2, 2029 3 years left